Skip to main content
Fig. 1 | BMC Pharmacology and Toxicology

Fig. 1

From: Effect of aerosolized nicotine on human bronchial epithelial cells is amplified after co-administration with cannabidiol (CBD): a pilot in vitro study

Fig. 1

Comparison of cellular toxicity and levels of released inflammatory mediators (cytokines) from H292 bronchial epithelial cells directly exposed at the air-liquid interface to 55 puffs of nicotine and CBD aerosols. All aerosol was generated from an eGO tank system, with battery output voltage set to 3.8 V and refilled with PG-only solution with the same nicotine and CBD concentrations (1.7 mg/mL). * indicates significant difference from the air control and # indicates significant difference from the PG solvent control

Back to article page